| Trial registration number
|
NCT04885764 |
Full text link
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04885764
|
First author
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
Samia Girgis, MD
|
Contact
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
drsamia.girgis@med.asu.edu.eg
|
Registration date
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
2021-05-13
|
Recruitment status
Last imported at : May 8, 2023, midnight
Source : ClinicalTrials.gov
|
Unknown
|
Study design
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
nonRCT
|
Allocation
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
Non-randomized
|
Design
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
Prevention
|
Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
age > 18 years old
candidate for receiving vaccination according to health care authorties prioritaizaton
|
Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
sars-cov-2 recovered cases <3 months
individuals who are currently infected with sars-cov-2 and/or with respiratory symptoms with fever.
|
Number of arms
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
Ain Shams University
|
Inclusion age min
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
Egypt
|
Type of patients
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
Healthy volunteers
|
Severity scale
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
N/A
|
Total sample size
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
4000
|
primary outcome
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
Short-term effectiveness
|
Notes
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
Declared number of arm (None) differs from found arms (1.0)
|
Phase
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
Phase 2/Phase 3
|
Arms
Last imported at : May 15, 2021, 12:32 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "2;3 months apart;IM", "treatment_id": 161, "treatment_name": "Chadox1 ncov-19", "treatment_type": "Non replicating viral vector", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "2;3 weeks apart;IM", "treatment_id": 1923, "treatment_name": "Inactivated sars-cov-2 vaccine (vero cell)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}]
|